Skip to content
10-Q

Quarterly Report

GFR PHARMACEUTICALS INC

0001437749-13-005919

← back to feed
Filed
May 14, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 14, 2013 42.08M sh
Capex Q1 2013 · Mar 31, 2013 $3.23K
Operating Cash Flow Q1 2013 · Mar 31, 2013 $494.41K
Operating Cash Flow Q1 2013 · Mar 31, 2012 −$44.12K
Cash And Equivalents Q1 2013 · Mar 31, 2013 $1.05M
Cash And Equivalents Q1 2013 · Dec 31, 2012 $564.55K
Cash And Equivalents Q1 2013 · Mar 31, 2012 $419.78K
Cash And Equivalents Q1 2013 · Dec 31, 2011 $460.88K
Stockholders Equity Q1 2013 · Mar 31, 2013 $10.02M
Stockholders Equity Q1 2013 · Dec 31, 2012 $9.83M
Current Liabilities Q1 2013 · Mar 31, 2013 $696.82K
Current Liabilities Q1 2013 · Dec 31, 2012 $739.53K
Total Liabilities Q1 2013 · Mar 31, 2013 $1.55M
Total Liabilities Q1 2013 · Dec 31, 2012 $1.59M
Current Assets Q1 2013 · Mar 31, 2013 $1.93M
Current Assets Q1 2013 · Dec 31, 2012 $1.43M
Total Assets Q1 2013 · Mar 31, 2013 $12.33M
Total Assets Q1 2013 · Dec 31, 2012 $12.17M
Sga Expense Q1 2013 · Mar 31, 2013 $168.89K
Sga Expense Q1 2013 · Mar 31, 2012 $230.22K
Net Income Q1 2013 · Mar 31, 2013 $153.85K
Net Income Q1 2013 · Mar 31, 2012 $317.29K
Operating Income Q1 2013 · Mar 31, 2013 $215.25K
Operating Income Q1 2013 · Mar 31, 2012 $428.87K
Gross Profit Q1 2013 · Mar 31, 2013 $454.6K
Gross Profit Q1 2013 · Mar 31, 2012 $728.75K
Cost Of Revenue Q1 2013 · Mar 31, 2013 $351.17K
Cost Of Revenue Q1 2013 · Mar 31, 2012 $186.1K
Revenue Q1 2013 · Mar 31, 2013 $805.77K
Revenue Q1 2013 · Mar 31, 2012 $914.85K